Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
July 03, 2024 08:00 ET
|
Olink Proteomics AB
Inaugural network of Olink® Certified Service Providers includes eading contract research organizations (CROs) and service labs around the world.
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest
May 09, 2024 09:00 ET
|
Curia Global, Inc.
The symposium, Unlocking High-Throughput Biology in Drug Discovery, will take place on May 31 in Seattle and feature industry-leading scientists.
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
November 05, 2023 20:00 ET
|
Olink Proteomics AB
Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.
Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics
October 05, 2023 16:25 ET
|
Olink Proteomics AB
Three landmark studies published in Nature demonstrate the power of Olink technology for understanding human biology.
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
September 28, 2023 08:00 ET
|
Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
Orion Biotechnology Completes Discovery of First-in-Class Molecule Against Undrugged GPCR Target in Four Months
July 18, 2023 11:33 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, July 18, 2023 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd. (Orion), a drug discovery and development company unlocking the therapeutic potential of previously undruggable G...
Chemical Computing Group and Discngine Join Forces
December 22, 2022 15:00 ET
|
Chemical Computing Group
MONTREAL, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Chemical Computing Group ULC ("CCG") announced today that it has acquired Discngine SAS ("Discngine"), a company that develops state-of-the-art IT...
Deepfake Technology in Drug Design
October 20, 2022 12:00 ET
|
InSilico Medicine
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create...
Healthcare Triangle Facilitates Secure Data Sharing for Drug Discovery Through Neutral Zone
July 05, 2022 08:00 ET
|
Healthcare Triangle, Inc.
PLEASANTON, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company") enables collaborative data sharing and analysis through “neutral zone”. A...
InveniAI Enters Strategic Artificial Intelligence Collaboration with Kyowa Hakko Kirin
December 11, 2018 08:00 ET
|
InveniAI
BRANFORD, Conn., Dec. 11, 2018 (GLOBE NEWSWIRE) -- InveniAI® Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML) to transform...